Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro

British Journal of Pharmacology

Volumn 139, Issue 1, 2003, Pages 21-27

  Tognetto, Michele ^a   D'Andrea, Michael R ^b   Trevisani, Marcello ^a   Guerrini, Remo ^c   Salvadori, Severo ^c   Spisani, Lorella ^a   Daniele, Carlo ^a   Andrade Gordon, Patricia ^b   Geppetti, Pierangelo ^a,c   Harrison, Selena ^a  

^a S ANNA HOSPITAL   (Italy)

^b R W Johnson Pharmaceutical Res I   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Human renal artery; Protease activated receptor 1 (PAR 1); Thrombin

Indexed keywords

NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; TRYPSIN;

ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; RENAL ARTERY;

CULTURE TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDES; PHENYLEPHRINE; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RECEPTORS, THROMBIN; RENAL ARTERY; THROMBIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 12444285764     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705215     Document Type: Article

References (39)

1. 2, in rat vascular and gastric smooth muscle. Can. J. Physiol. Pharmacol., 73, 1203-1207.
2. CONNOLLY, A.J., ISHIHARA, H., KAHN, M.L., FARESE JR R. & COUGHLIN, S.R. (1996). Role of the thrombin receptor in development and evidence for a second receptor. Nature, 381, 516-519.
3. COUGHLIN, S.R., VU, T.K., HUNG, D.T. & WHEATON, V.I. (1992). Characterization of a functional thrombin receptor. Issues and opportunities. J. Clin. Invest., 89, 351-355.
4. DAMIANO, B.P., D'ANDREA, M.R., DE GARAVILLA, L., CHEUNG, W.M. & ANDRADE-GORDON, P. (1999). Increased expression of protease activated receptor-2 (PAR-2) balloon-injured rat carotid artery. Thromb. Haemost., 81, 808-814.
5. D'ANDREA, M.R., DERIAN, C.K., LETURCQ, D., BAKER, S.M., BRUNMARK, A., LING, P., DARROW, A.L., SANTULLI, R.J., BRASS, L.F. & ANDRADE-GORDON, P. (1998). Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J. Histochem. Cytochem., 46, 157-164.
6. D'ANDREA, M.R., ROGAHN, C.J. & ANDRADE-GORDON, P. (2000). Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade. Biotech. Histochem., 75, 85-90.
7. DERKACH, D.M., IHARA, E., HIRANO, K., NISHIMURA, J., TAKAHASHI, S. & KANAIDE, H. (2000). Thrombin causes endothelium-dependent biphasic regulation of vascular tone in the porcine renal interlobar artery. Br. J. Pharmacol., 131, 1635-1642.
8. DERY, O., CORVERA, C.U., STEINHOFF, M. & BUNNETT, N.W. (1998). Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol., 274, C1429-C1452.
9. FARUQI, T.R., WEISS, E.J., SHAPIRO, M.J., HUANG, W. & COUGHLIN, S.R. (2000). Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. J. Biol. Chem., 275, 19728-19734.
10. FOX, M.T., HARRIOTT, P., WALKER, B. & STONE, S.R. (1997). Identification of potential activators of proteinase-activated receptor-2. FEBS Lett., 417, 267-269.
11. HAMILTON, J.R. & COCKS, T.M. (2000). Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery. Br. J. Pharmacol., 130, 181-188.
12. HAMILTON, J.R., FRAUMAN, A.G. & COCKS, T.M. (2001a). Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ. Res., 89, 92-98.
13. HAMILTON, J.R., MOFFATT, J.D., FRAUMAN, A.G. & COCKS, T.M. (2001b). Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries. J. Cardiovasc. Pharmacol., 38, 108-119.
14. HAMILTON, J.R., NGUYEN, P.B. & COCKS, T.M. (1998). A typical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. Circ. Res., 82, 1306-1311.
15. HOLLENBERG, M.D. (1996). Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol. Sci., 17, 3-6.
16. HOLLENBERG, M.D. & COMPTON, S.J. (2002). International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol. Rev., 54, 203-217.
17. HWA, J.J., GHIBAUDI, L., WILLIAMS, P., CHINTALA, M., ZHANG, R., CHATTERJEE, M. & SYBERTZ, E. (1996). Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ. Res., 78, 581-588.
18. ISHIHARA, H., CONNOLLY, A.J., ZENG, D., KAHN, M.L., ZHENG, Y.W., TIMMONS, C., TRAM, T. & COUGHLIN, S.R. (1997). Protease-activated receptor 3 is a second thrombin receptor in humans. Nature, 386, 502-506.
19. KAHN, M.L., ZHENG, Y.W., HUANG, W., BIGORNIA, V., ZENG, D., MOFF, S., FARESE, R.V., TAM, C. & COUGHLIN, S.R. (1998). A dual thrombin receptor system for platelet activation. Nature, 394, 690-694.
20. KINLOUGH-RATHBONE, R.L., PERRY, D.W., GUCCIONE, M.A., RAND, M.L. & PACKHAM, M.A. (1993). Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Thromb. Haemost., 70, 1019-1023.
21. KU, D.D. & DAI, J. (1997). Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. J. Cardiovasc. Pharmacol., 30, 649-657.
22. KU, D.D. & ZALESKI, J.K. (1993). Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs. J. Cardiovasc. Pharmacol., 22, 609-916.
23. LANIYONU, A.A. & HOLLENBERG, M.D. (1995). Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta. Br. J. Pharmacol., 114, 1680-1686.
24. MIRZA, H., SCHMIDT, V.A., DERIAN, C.K., JESTY, J. & BAHOU, W.F. (1997). Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood, 90, 3914-3922.
25. MOFFATT, J.D. & COCKS, T.M. (1998). Endothelium-dependent and - independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries. Br. J. Pharmacol., 125, 591-594.
26. MOLINO, M., WOOLKALIS, M.J., REAVEY-CANTWELL, J., PRATICO, D., ANDRADE-GORDON, P., BARNATHAN, E.S. & BRASS, L.F. (1997). Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J. Biol. Chem., 272, 11133-11141.
27. MURAMATSU, I., LANIYONU, A., MOORE, G.J. & HOLLENBERG, M.D. (1992). Vascular actions of thrombin receptor peptide. Can. J. Physiol. Pharmacol., 70, 996-1003.
28. NYSTEDT, S., EMILSSON, K., WAHLESTEDT, C. & SUNDELIN, J. (1994). Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 9208-9212.
29. ROY, S.S., SAIFEDDINE, M., LOUTZENHISER, R., TRIGGLE, C.R. & HOLLENBERG, M.D. (1998). Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br. J. Pharmacol., 123, 1434-1440.
30. SAIFEDDINE, M., AL-ANI, B., CHENG, C.H., WANG, L. & HOLLENBERG, M.D. (1996). Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br. J. Pharmacol., 118, 521-530.
31. SMITH-SWINTOSKY, V.L., CHEO-ISAACS, C.T., D'ANDREA, M.R., SANTULLI, R.J., DARROW, A.L. & ANDRADE-GORDON, P. (1997). Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J. Neurochem., 69, 1890-1896.
32. SOBEY, C.G. & COCKS, T.M. (1998). Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke, 29, 1439-1444.
33. SOBEY, C.G., MOFFATT, J.D & COCKS, T.M. (1999). Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. Stroke, 30, 1933-1940.
34. TAY-UYBOCO, J., POON, M.C., AHMAD, S. & HOLLENBERG, M.D. (1995). Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systems. Br. J. Pharmacol., 115, 569-578.
35. TESFAMARIAM, B. (1994). Distinct receptors and signaling pathways in alpha- thrombin- and thrombin receptor peptide-induced vascular contractions. Circ. Res., 74, 930-936.
36. VU, T.K., HUNG, D.T., WHEATON, V.I. & COUGHLIN, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057-1068.
37. WALZ, D.A., ANDERSON, G.F., CIAGLOWSKI, R.E., AIKEN, M. & FENTON, J.W.D. (1985). Thrombin-elicited contractile responses of aortic smooth muscle. Proc. Soc. Exp. Biol. Med., 180, 518-526.
38. WHITE, R.P., CHAPLEAU, C.E., DUGDALE, M. & ROBERTSON, J.T. (1980). Cerebral arterial contractions induced by human and bovine thrombin. Stroke, 11, 363-368.
39. XU, W.F., ANDERSEN, H., WHITMORE, T.E., PRESNELL, S.R., YEE, D.P., CHING, A., GILBERT, T., DAVIE, E.W. & FOSTER, D.C. (1998). Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U.S.A., 95, 6642-6646.